Hemostemix Inc. (CVE:HEM – Get Free Report) shares crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.08 and traded as low as C$0.07. Hemostemix shares last traded at C$0.07, with a volume of 8,000 shares.
Hemostemix Trading Down 12.5 %
The firm has a market cap of C$6.10 million, a P/E ratio of -3.50 and a beta of 0.20. The business’s fifty day simple moving average is C$0.08 and its 200-day simple moving average is C$0.07.
About Hemostemix
Hemostemix Inc, a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, an autologous cell therapy, which is in Phase II clinical trial for the treatment of vascular diseases, such as cardiovascular disease, peripheral arterial disease, angina pectoris, and ischemia.
Read More
- Five stocks we like better than Hemostemix
- What is the Euro STOXX 50 Index?
- Top 3 Investment Themes to Watch for in 2025
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What is a Bond Market Holiday? How to Invest and Trade
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Hemostemix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hemostemix and related companies with MarketBeat.com's FREE daily email newsletter.
